Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Zola

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Pharmacy|July 1, 1992
Use of surfactant productsE M Zola
Archives of Disease in Childhood|October 1, 1991
Surfactant treatment for premature babies--a review of clinical trialsE M Zola
Drug Intelligence & Clinical Pharmacy|September 1, 1984
Evaluation of drugs used in the prophylaxis of neonatal conjunctivitisE M Zola
Drug Intelligence & Clinical Pharmacy|June 1, 1983
Comparative effects and analgesic efficacy of the agonist-antagonist opioidsE M Zola, D C McLeod
British Journal of Clinical Pharmacology|October 1, 1984
Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoproteinJ J MacKichan, E M Zola
Drug Intelligence & Clinical Pharmacy|October 1, 1984
Issues facing nutrition support teamsS C Finn, E M Zola, J F Sheridan
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Efficacy of a timed-release antihistamine/decongestant tablet for symptoms of nasal allergyJ T Connell, A J Gold, E M Zola, et al.
The Journal of Pediatrics|February 21, 1998
Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study GroupA Lotze, B R Mitchell, D I Bulas, et al.
Clinical Pharmacology and Therapeutics|September 1, 1994
Differential absorption of amoxicillin from the human small and large intestineW H Barr, E M Zola, E L Candler, et al.
Pediatrics|March 1, 1993
Treatment Investigational New Drug experience with Survanta (beractant)E M Zola, A M Overbach, J H Gunkel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Pharmacy|July 1, 1992
Use of surfactant productsE M Zola
Archives of Disease in Childhood|October 1, 1991
Surfactant treatment for premature babies--a review of clinical trialsE M Zola
Drug Intelligence & Clinical Pharmacy|September 1, 1984
Evaluation of drugs used in the prophylaxis of neonatal conjunctivitisE M Zola
Drug Intelligence & Clinical Pharmacy|June 1, 1983
Comparative effects and analgesic efficacy of the agonist-antagonist opioidsE M Zola, D C McLeod
British Journal of Clinical Pharmacology|October 1, 1984
Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoproteinJ J MacKichan, E M Zola
Drug Intelligence & Clinical Pharmacy|October 1, 1984
Issues facing nutrition support teamsS C Finn, E M Zola, J F Sheridan
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Efficacy of a timed-release antihistamine/decongestant tablet for symptoms of nasal allergyJ T Connell, A J Gold, E M Zola, et al.
The Journal of Pediatrics|February 21, 1998
Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study GroupA Lotze, B R Mitchell, D I Bulas, et al.
Clinical Pharmacology and Therapeutics|September 1, 1994
Differential absorption of amoxicillin from the human small and large intestineW H Barr, E M Zola, E L Candler, et al.
Pediatrics|March 1, 1993
Treatment Investigational New Drug experience with Survanta (beractant)E M Zola, A M Overbach, J H Gunkel, et al.
Pageof 2